Skip to main content
. 2016 Sep 18;9(10):e35591. doi: 10.5812/jjm.35591

Figure 4. Latrunculin A and Nocodazole Affect CDT Activity in HeLa Cells.

Figure 4.

Flow cytometry analysis and morphological alterations in HeLa cells treatment with cytoskeletal inhibitors and CDT (10,000 nuclei were analyzed by sample). Panel A, cells without treatment; Panel B, cells treated with CDT; Panel C, cells treated with CDT + nocodazole; Panel D, cells treated with CDT + latrunculin A; Panel E, cells treated with CDT + nocodazole + latrunculin A.